BSE filing, NSE: BNALTD. Summary written from the filing by ALFA Finder's alert engine.
B&A Ltd: key numbers
- Share price
- ₹411.95
- Market cap
- ₹127.7 Cr
- Revenue (annual)
- ₹283.1 Cr
- Net profit (annual)
- ₹-3.94 Cr
- P/E (TTM)
- 175.0×Sector 26.8×
- Promoter holding
- 59.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from B&A Ltd
All →B&A Capital Structure Change
Siemens Syntex and related parties sold 50 B & A shares off-market on 17 Aug 2026. The revised SAST filing records the delivery with no stated value.
B&A Capital Structure Change
Siemens Syntex Pvt Ltd, a non-promoter, sold 50 shares of B & A Limited off-market following short delivery on 17.08.2026. The holding fell from 11.418% to 11.417%.
B&A Capital Structure Change
Siemens Syntex Private Limited, a non-promoter entity, acquired 1,000 equity shares of B & A Limited from the open market, increasing its stake.
B&A Capital Structure Change
Siemens Syntex Private Limited acquired 500 equity shares of B & A Limited via open market. The acquirer's group stake increased to 11.412%.
B&A Management Change
B & A Limited has appointed Mr. Raunak Barat as the Chief Financial Officer, effective November 1, 2026. This appointment strengthens the company's key managerial leadership.
B&A Q1 FY27 Results: Turns Profitable, Net Profit ₹2.6 Cr
B&A Ltd reported revenue from operations of ₹71.6 Cr (+28.8% YoY) and net profit of ₹2.6 Cr for Q1 FY27.
- Key figure
- Net profit ₹2.6 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.